Hsin-Ta Wu
Hsin-Ta Wu
Manager, Bioinformatics at Natera
Verified email at alumni.brown.edu - Homepage
Title
Cited by
Cited by
Year
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113-1120, 2013
39792013
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Cancer Genome Atlas Research Network
New England Journal of Medicine 368 (22), 2059-2074, 2013
30182013
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
29772014
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43, 2013
18942013
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
11232014
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ...
Nature genetics 47 (2), 106-114, 2015
6382015
Integrated genomic characterization of oesophageal carcinoma
Cancer Genome Atlas Research Network
Nature 541 (7636), 169, 2017
6122017
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
3782016
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer
T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ...
JAMA oncology 5 (8), 1124-1131, 2019
1772019
CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer
MDM Leiserson, HT Wu, F Vandin, BJ Raphael
Genome biology 16 (1), 1-20, 2015
1672015
An integrative probabilistic model for identification of structural variation in sequencing data
SS Sindi, S Önal, LC Peng, HT Wu, BJ Raphael
Genome biology 13 (3), 1-25, 2012
1572012
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ...
Journal of Clinical Oncology 37 (18), 1547-1557, 2019
1202019
The integrated genomic landscape of thymic epithelial tumors
M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ...
Cancer cell 33 (2), 244-258. e10, 2018
1172018
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
RC Coombes, K Page, R Salari, RK Hastings, A Armstrong, S Ahmed, ...
Clinical Cancer Research 25 (14), 4255-4263, 2019
992019
Identification of ovarian cancer metastatic miRNAs
S Vang, HT Wu, A Fischer, DH Miller, S MacLaughlan, E Douglass, ...
PloS one 8 (3), e58226, 2013
882013
Identification of ovarian cancer metastatic miRNAs
S Vang, HT Wu, A Fischer, DH Miller, S MacLaughlan, E Douglass, ...
PloS one 8 (3), e58226, 2013
882013
Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease
AS Brodsky, A Fischer, DH Miller, S Vang, S MacLaughlan, HT Wu, J Yu, ...
PloS one 9 (4), e94476, 2014
522014
Identifying structural variants using linked-read sequencing data
R Elyanow, HT Wu, BJ Raphael
Bioinformatics 34 (2), 353-360, 2018
472018
An online literature mining tool for protein phosphorylation
X Yuan, ZZ Hu, HT Wu, M Torii, M Narayanaswamy, KE Ravikumar, ...
Bioinformatics 22 (13), 1668-1669, 2006
372006
Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant …
MJM Magbanua, L Brown-Swigart, GL Hirst, C Yau, D Wolf, AA Ma, ...
Cancer Research 79 (4 Supplement), PD2-01-PD2-01, 2019
332019
The system can't perform the operation now. Try again later.
Articles 1–20